Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Critics challenge DEI as ‘immoral’; this VC has a message for those seeking equity for Black, Brown founders: We are not powerless
Pushing for equity in long-siloed industries might seem obvious to some, said Marcus Whitney, but advocates for change must remember that not everyone is on board — and some are actively working against level the playing field. “I hate to say it, but we have enemies,” Whitney told a crowd gathered Thursday at Vine Street…
Not excited about these 3 Downtown KC projects? ‘You need to have your pulse checked’
It’s never been a better time for businesses in Downtown Kansas City, shared Mike Klamm. “A lot of us are Kansas City natives, and if you’re not excited about where we are right now, I do think you need to have your pulse checked,” said Klamm, chair of the Downtown Council board and senior vice…
Donutology’s trolley adds new flavor to River Market with streetcar shop stop’s opening
Kansas City’s new treat trolley has arrived with Friday’s opening of the new Donutology donut shop within a 70-year-old repurposed streetcar in River Market. Just a few months after news broke that Donutology would take over the space at 426 Delaware St. — formerly a Made in KC micro location — the business opened its…
Acquiring company: Homebase’s KC team will make valuable workforce, leadership additions
Homebase’s acquisition by an industry leader in the smart home space this week gives its Kansas City team a greater voice in redefining the future of living, said Blake Miller, sharing details of what the exit means for the talent at his Crossroads headquarters. “We’ve created an entirely new category in an industry (real estate)…